ICU Medical

Rank: 86
2016 Rank95
R&D Spend:$12,955,000
Fiscal year ending:12-31-16
Click here to see all 100

New Study Shows ICU Medical Infusion Systems Are Associated with a Reduction in Hazardous Drug Exposure. Our products help clinicians improve patient outcomes by minimizing bacterial ingress that can cause bloodstream infections and preventing exposure to infectious diseases or hazardous drugs. Our diverse product line includes needlefree vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, advanced sensor catheters, needlefree closed blood sampling systems, and innovative hemodynamic monitoring systems.

B. Braun and ICU Medical Sign Expanded Long-Term International Distribution Agreement. ICU Medical Partners with Medline Industries to Acquire Excelsior Medical Corporation.

Big 100 Mini Logo Key Personnel: Vivek Jain, chairman & CEO; Alison Burcar, VP & GM; Scott Lamb, CFO; Tom McCall, VP & GM; Steven Riggs, VP, operations.;

San Clemente, California